|Mr. Todd Newton||CEO & Director||546.1k||N/A||1963|
|Ms. Stefanie L. Cavanaugh||CFO, Treasurer & Sec.||356.73k||N/A||1965|
|Mr. Bret Schwartzhoff||VP, US Sales & Global Marketing||343k||N/A||1973|
|Dr. Sergey Kantsevoy M.D.||Co-Founder and Innovation Partner||N/A||N/A||N/A|
|Mr. Anthony Kalloo M.D.||Co-Founder and Innovation Partner||N/A||N/A||N/A|
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. Its products include OverStitch and OverStitch Sx Endoscopic Suturing System that enables advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope; Orbera365 Managed Weight Loss System; and the BIB for the treatment of overweight and obese adults. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Apollo Endosurgery, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.